Rapid, Safe and Effective Vaccines for Global Health

Solaris Vaccines, Inc. was formed 2021 to address many of the challenges of creating vaccines in response to emerging threats to global human health. 

Current methods of developing and manufacturing vaccines are slow, not fully protective, technically complex, use toxic chemicals, and often have onerous storage requirements.

The Solaris SolaVAX™ method uses riboflavin (vitamin B2) and UV light to rapidly and effectively inactivate pathogens, resulting in a new approach for creating vaccines against pathogens such as viruses, bacteria and parasites.